In addition to Morgan Stanley, GlaxoSmithKline also received a Sell from J.P. Morgan’s Zain Ebrahim in a report issued today. However, on January 8, Deutsche Bank maintained a Hold rating on ...
The pharmaceutical and biotechnology company GlaxoSmithKline has fired one of their employees who launched into a homophobic and racist rant whilst on an American Airlines flight. In viral video ...
GSK plc (NYSE:GSK) is one of the best performing pharma stocks in 2025. Jefferies reaffirmed a Buy rating on GSK plc ...
An announcement from GlaxoSmithKline ( (GB:GSK)) is now available. GSK plc has continued its share buyback programme, repurchasing 232,912 ordinary shares on 19 December 2025 through BNP Paribas at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback